Tradestie Institutional Equity Comparison Engine

MYO vs CTKB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CTKB Overall Edge

CTKB Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cytek Biosciences, Inc. Common Stock (CTKB) driven by superior Momentum & Technical, Options & Structure while MYO counters with relative strength in Growth & Margin. Fundamentally, MYO trades at N/M Forward P/E with -21.8% operating margin (+22.2% YoY revenue) versus CTKB at N/M Forward P/E and -22.5% operating margin (+1.8% YoY). In options structure, MYO sits in UNCLASSIFIED (81st %ile IV; Dealer Gamma Walls on Pro) against CTKB sits in CONSOLIDATION (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MYO N/M vs CTKB N/M Fwd P/E
Growth & Margin Winner MYO
Op Margin -21.8% vs -22.5% ยท YoY +22.2% vs +1.8%
Momentum & Technical Winner CTKB
1Y +12.3% vs +16.4% ยท 52W Pos 16% vs 91%
Options & Structure Winner CTKB
UNCLASSIFIED (81st %ile IV) vs CONSOLIDATION (<1st %ile IV)
MYO NYSE American
Myomo Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.81
-3.45% 1D
Market Cap $33.7M
1M Return -33.52%
1Y Return +12.3%
Forward P/E N/M
Unified AI Score
40.1 / 100 SELL
Tech 25.0 Fund 43.0 Flow 58.0 Mom 59.0
CTKB NASDAQ
Cytek Biosciences, Inc. Common Stock
Laboratory Analytical Instruments
$6.12
-3.16% 1D
Market Cap $826.6M
1M Return +12.71%
1Y Return +16.35%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 33.0 Fund 44.0 Flow 60.0 Mom 41.1

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MYO +12.3% CTKB +16.35% Spread: +4.05 pp (CTKB Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period MYO Revenue CTKB Revenue MYO Op. Margin CTKB Op. Margin Margin Edge
FY2018 $0M N/A -430.8% N/A MYO
FY2019 $0M N/A -281.3% N/A MYO
FY2020 $10M $90M -138.5% 14.7% CTKB
FY2021 $10M $130M -74.1% 7.2% CTKB
FY2022 $20M $160M -68.6% -1.1% CTKB
FY2023 $20M $190M -42.8% -14.4% CTKB
FY2024 $30M $200M -19.1% -10.2% CTKB
FY2025 $40M $200M -35.2% -20.0% CTKB

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MYO (3) vs CTKB (5)
Institutional Metric MYO CTKB Criterion Row Winner
Market Capitalization Scale $33.7M $826.6M Larger Scale CTKB
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +22.2% +1.8% Higher Growth MYO
Operating Margin (TTM) Profitability -21.8% -22.5% Higher Margin MYO
Net Profit Margin Profitability -33.1% -39.1% Higher Margin MYO
Return on Equity (ROE) Capital Efficiency -173.5% -23.2% Higher ROE CTKB
52-Week Range Position Momentum 16% ($1โ€“$2) 91% ($3โ€“$6) Stronger Trend CTKB
Beta / 30D Volatility Risk Regime 2.22ฮฒ ยท 107% Vol 0.71ฮฒ ยท 67% Vol Lower Realized Risk CTKB
Unified Institutional Score Composite Signal 40.1 / 100 (SELL) 48.4 / 100 (HOLD) Higher Composite CTKB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MYO vs CTKB Buy Guide
MYO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 81st %ile
IV Regime Extreme (>80th %ile)
Live MYO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CTKB CONSOLIDATION
16d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live CTKB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MYO nor CTKB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.